Key statistics
On Wednesday, Resmed Inc (RMD:NYQ) closed at 247.21, -5.10% below its 52-week high of 260.49, set on Oct 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 248.81 |
---|---|
High | 249.27 |
Low | 246.19 |
Bid | 225.00 |
Offer | 260.00 |
Previous close | 248.69 |
Average volume | 989.13k |
---|---|
Shares outstanding | 146.80m |
Free float | 145.64m |
P/E (TTM) | 32.77 |
Market cap | 36.29bn USD |
EPS (TTM) | 7.54 USD |
Annual div (ADY) | 2.12 USD |
---|---|
Annual div yield (ADY) | 0.86% |
Div ex-date | Nov 07 2024 |
Div pay-date | Dec 12 2024 |
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
- ResMed Announces Participation in the UBS Global Healthcare Conference
- ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
- ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
- ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
- UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
- UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
- ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
- Vaping Expected to Increase COPD Health and Economic Burden by 2050
- ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
- ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
More ▼